Dosimetric correlation of radiation-induced chronic kidney disease (CKD): a competing risks analysis
In brief
Mean kidney dose at least 10 Gy raises 7-year CKD risk to 56%
In 126 women treated with extended-field radiotherapy, a mean kidney dose of 10 Gy or more led to a 56% cumulative incidence of stage 3 or worse chronic kidney disease at 7 years, compared with 17% when the dose was kept below 5 Gy. 73 m², suggesting current dose limits may be too high.
- Journal
- Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology (Q1)
- Published
- 22 September 2026
- Study design
- Cohort / observational study
- Evidence level
- Level 3, Low (CEBM 3b)
- Authors
- Yu-Ming Wang, Chung-Shih Chen, Jen-Yu Cheng, Chong-Jong Wang, Eng-Yen Huang
- PMID
- 42772457
- DOI
- 10.1016/j.radonc.2026.111793
Why clinicians should know about it
- Picked for Medical Physics (paper of the day, 24 September 2026): Radiation-induced CKD correlated with mean kidney dose
- Picked for Radiation Oncology (paper of the day, 24 September 2026): Kidney dose correlates with radiation‑induced CKD risk
Abstract
BACKGROUND AND PURPOSE: To determine the competing risks (CR) cumulative incidence of radiation-induced chronic kidney disease (CKD) and identify independent dosimetric predictors in patients receiving radiotherapy (RT) involving the para-aortic lymph nodes (PALNs), providing evidence to refine kidney dose constraints in contemporary RT planning. MATERIALS AND METHODS: From November 2000 to September 2023, 126 patients with gynecological malignancies receiving extended-field RT (EFRT) or salvage PALN RT were retrospectively analyzed. The planned PALN dose was 39.6-62 Gy/22-31 fractions. Patients with baseline estimated glomerular filtration rate (eGFR) < 60 ml/min/1.73 m2 were excluded. CKD was defined as stage 3A (eGFR < 60 ml/min/1.73 m2) or stage 3B (eGFR < 45 ml/min/1.73 m2). Mean kidney dose (MKD) groups: Group 1 (<5 Gy), Group 2 (5-9.9 Gy), and Group 3 (≥10 Gy). CR analysis with Gray's test and the Fine-Gray subdistribution hazard model accounted for the competing risk of death without CKD. RESULTS: After a median follow-up of 55 months, 7-year CR cumulative incidences of stage ≥ 3A CKD were 17.0 %, 20.9 %, and 55.7 % in Groups 1, 2, and 3 (p = 0.008), respectively; corresponding rates for stage ≥ 3B CKD were 0 %, 13.9 %, and 26.4 % (p = 0.041). Patients with pre-RT eGFR < 75 ml/min/1.73 m2 had significantly higher 7-year CR rates of stage 3A (57.1 % vs. 23.2 %; p < 0.001) and stage 3B CKD (37.2 % vs. 7.6 %; p = 0.005). Multivariate CR analysis identified MKD group (p = 0.012) and pre-RT eGFR < 75 ml/min/1.73 m2 (p = 0.023) as independent predictors of stage 3B CKD. CONCLUSIONS: Radiation-induced CKD is significantly correlated with MKD and baseline eGFR. Even MKD values of 5-9.9 Gy carry measurable risk of stage 3B CKD-below the QUANTEC-recommended ceiling of 15-18 Gy-suggesting that stricter MKD constraints (< 5 Gy) are warranted, particularly in patients with pre-RT eGFR < 75 ml/min/1.73 m2.
Abstract as published, via PubMed.
For healthcare professionals. The summary is generated by AI from the published abstract, and the evidence level is assigned automatically from the study design on the Oxford CEBM hierarchy. Neither is medical advice. Read the full paper before changing practice.